Hideaki Miwa

1.1k total citations
65 papers, 840 citations indexed

About

Hideaki Miwa is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Hideaki Miwa has authored 65 papers receiving a total of 840 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Oncology, 15 papers in Pulmonary and Respiratory Medicine and 14 papers in Molecular Biology. Recurrent topics in Hideaki Miwa's work include Lymphoma Diagnosis and Treatment (11 papers), Gastrointestinal Tumor Research and Treatment (5 papers) and Antibiotic Resistance in Bacteria (5 papers). Hideaki Miwa is often cited by papers focused on Lymphoma Diagnosis and Treatment (11 papers), Gastrointestinal Tumor Research and Treatment (5 papers) and Antibiotic Resistance in Bacteria (5 papers). Hideaki Miwa collaborates with scholars based in Japan, Malaysia and South Korea. Hideaki Miwa's co-authors include Katsuyuki Aozasa, Minoru Suzuki, Charles Santhanaraju Vairappan, Masahiko Ohsawa, Shin‐ichi Nakatsuka, Hiroyuki Kanno, Hideaki Tsukuma, Michiko Hashimoto, Hirofumi Teshima and Harumasa Yoshihara and has published in prestigious journals such as Cancer, Antimicrobial Agents and Chemotherapy and International Journal of Cancer.

In The Last Decade

Hideaki Miwa

60 papers receiving 815 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hideaki Miwa Japan 17 266 218 197 114 109 65 840
Malihe Hasanzadeh Iran 19 375 1.4× 654 3.0× 126 0.6× 41 0.4× 159 1.5× 77 1.5k
Norio Unemi Japan 16 503 1.9× 308 1.4× 37 0.2× 115 1.0× 121 1.1× 49 920
Jiaqi Xiao China 23 191 0.7× 575 2.6× 254 1.3× 752 6.6× 154 1.4× 37 1.7k
Alexandre Evrard France 25 711 2.7× 841 3.9× 73 0.4× 42 0.4× 109 1.0× 80 1.9k
David T. Coleman United States 15 120 0.5× 284 1.3× 118 0.6× 19 0.2× 42 0.4× 21 767
Flavia Girolami Italy 13 189 0.7× 387 1.8× 60 0.3× 32 0.3× 35 0.3× 41 1.0k
Ward Jm United States 16 262 1.0× 304 1.4× 109 0.6× 38 0.3× 103 0.9× 34 950
Xiang Pan China 21 107 0.4× 773 3.5× 44 0.2× 185 1.6× 110 1.0× 90 1.5k
Osamu Tsuruta Japan 24 705 2.7× 373 1.7× 147 0.7× 134 1.2× 637 5.8× 108 2.0k

Countries citing papers authored by Hideaki Miwa

Since Specialization
Citations

This map shows the geographic impact of Hideaki Miwa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hideaki Miwa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hideaki Miwa more than expected).

Fields of papers citing papers by Hideaki Miwa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hideaki Miwa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hideaki Miwa. The network helps show where Hideaki Miwa may publish in the future.

Co-authorship network of co-authors of Hideaki Miwa

This figure shows the co-authorship network connecting the top 25 collaborators of Hideaki Miwa. A scholar is included among the top collaborators of Hideaki Miwa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hideaki Miwa. Hideaki Miwa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nakamura, Jun, et al.. (2019). Anti-mitochondria antibody-related tubulointerstitial nephritis accompanied by severe hypokalemic paralysis. CEN Case Reports. 8(2). 119–124. 1 indexed citations
2.
Yamamichi, Gaku, et al.. (2019). High diagnostic efficacy of 5-aminolevulinic acid-induced fluorescent urine cytology for urothelial carcinoma. International Journal of Clinical Oncology. 24(9). 1075–1080. 15 indexed citations
3.
4.
Miyake, Yuichiro, Junichi Hasegawa, Shoki Mikata, et al.. (2014). A Case of Rectal Carcinoid Detected by Nodal Metastasis. The Japanese Journal of Gastroenterological Surgery. 47(6). 357–363. 4 indexed citations
5.
Mikata, Shoki, Yukihiro Yoshikawa, Yuichiro Miyake, et al.. (2013). [Two cases of human epidermal growth factor receptor 2-positive advanced gastric cancer successfully treated with S-1, cisplatin, and trastuzumab combination therapy followed by curative resection].. PubMed. 40(12). 2203–6. 1 indexed citations
6.
Hirota, Masaki, et al.. (2013). A Case Report of Transverse Colon Carcinoma with Jejunocolic and Colocolic Fistula. Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association). 74(9). 2551–2556.
7.
Koyama, Shinsuke, Masaki Kobayashi, Yusuke Tanaka, et al.. (2013). Laparoscopic Repair of a Post-Myomectomy Spontaneous Uterine Perforation Accompanied by a Bizarre Tumor Resembling Polypoid Endometriosis. Journal of Minimally Invasive Gynecology. 20(6). 912–916. 4 indexed citations
8.
Yamawaki, Kenji, Takashi Nomura, Tatsuro Yasukata, et al.. (2007). A novel series of parenteral cephalosporins exhibiting potent activities against Pseudomonas aeruginosa and other Gram-negative pathogens: Synthesis and structure–activity relationships. Bioorganic & Medicinal Chemistry. 15(21). 6716–6732. 22 indexed citations
9.
Nomura, Takashi, et al.. (2006). A new type of ketolide bearing an N-aryl-alkyl acetamide moiety at the C-9 iminoether: Synthesis and structure–activity relationships (2). Bioorganic & Medicinal Chemistry. 14(11). 3697–3711. 12 indexed citations
10.
Vairappan, Charles Santhanaraju, et al.. (2004). Potent Antibacterial Activity of Halogenated Compounds against Antibiotic-Resistant Bacteria. Planta Medica. 70(11). 1087–1090. 78 indexed citations
11.
12.
Nakatsuka, Shin‐ichi, Yasuhiko Tomita, Hideaki Miwa, et al.. (2002). Enhanced Expression of Neuron‐specific Enolase (NSE) in Pyothorax‐associated Lymphoma (PAL). Japanese Journal of Cancer Research. 93(4). 411–416. 17 indexed citations
13.
14.
Miwa, Hideaki, Junichi Fujii, Hiroyuki Kanno, Naoyuki Taniguchi, & Katsuyuki Aozasa. (2000). Pyruvate secreted by human lymphoid cell lines protects cells from hydrogen peroxide mediated cell death. Free Radical Research. 33(1). 45–56. 39 indexed citations
15.
Kuwahara, Yusuke, Ayumu Hirata, Hideaki Miwa, et al.. (2000). Epstein-Barr virus associated B-cell lymphoma of brain developing in myelodysplastic syndrome withc-kit mutation (Try-557 ? stop). American Journal of Hematology. 65(3). 234–238. 4 indexed citations
16.
Ohsawa, Masahiko, Shin‐ichi Nakatsuka, Hiroyuki Kanno, et al.. (1999). Immunophenotypic and genotypic characterization of nasal lymphoma with polymorphic reticulosis morphology. International Journal of Cancer. 81(6). 865–870. 43 indexed citations
17.
Ohsawa, Masahiko, Hideaki Miwa, Harumasa Yoshihara, et al.. (1999). Risk of non-Hodgkin's lymphoma in patients with hepatitis C virus infection. International Journal of Cancer. 80(2). 237–239. 73 indexed citations
18.
Hamashima, Yoshio, et al.. (1994). Synthesis and structure-activity relationships of 7.BETA.-((Z)-2-(2-aminothiazol-4-yl)-3-(substituted)-2-propenoylamino)-3-cephems with C-3 substitutions.. The Journal of Antibiotics. 47(4). 466–476. 8 indexed citations
19.
Hori, Kenji, et al.. (1992). In vivo antibacterial activity of vancomycin. Chemotherapy. 40(4). 451–458. 2 indexed citations
20.
SHOJI, JUN''ICHI, HIROSHI HINOO, Teruaki Katayama, et al.. (1992). Isolation and characterization of new peptide antibiotics, plusbacins A1-A4 and B1-B4.. The Journal of Antibiotics. 45(6). 817–823. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Malihe Hasanzadeh Breakdown of academic impact, for papers by Norio Unemi Breakdown of academic impact, for papers by Jiaqi Xiao Breakdown of academic impact, for papers by Alexandre Evrard Breakdown of academic impact, for papers by David T. Coleman Breakdown of academic impact, for papers by Flavia Girolami Breakdown of academic impact, for papers by Ward Jm Breakdown of academic impact, for papers by Xiang Pan Breakdown of academic impact, for papers by Osamu Tsuruta
Rankless by CCL
2026